We conducted a genome-wide analysis to identify differentially methylated genes in atherosclerotic lesions.
Introduction
Atherosclerosis is a major life-threatening condition responsible for almost one-third of all deaths globally (http://www.who.int/nmh/ publications/ncd_report2010/en/). However, it remains unknown how inheritable factors beyond DNA sequence, i.e. epigenetic changes, are involved in its pathogenesis. 1 DNA methylation affects about 1-4% of all cytosines, 2, 3 and up to 90% of cytosines in cytosine-guanosine (CpG) dinucleotides can become methylated. 4 Increased DNA methylation (hypermethylation) leads to transcriptional repression 5 which is mediated by methylcytosine binding proteins, while a decrease in DNA methylation (hypomethylation) leads to transcriptional activation via recruitment of activating histone methylases. 6 Altered DNA methylation has been demonstrated for a number of individual genes in atherosclerosis. 7 While the promoter areas of some genes like ERalpha, 8 HIF1alpha, 9 myc, 10 MCT3, 11 and CTCF 12 become hypermethylated, some others like 15-LO 3 and EC-SOD 13 have been shown to lose their DNA methylation marks. Also, events during early life (e.g. low birth weight) appear to contribute to cardiovascular health in next generations implicating epigenetic mechanisms 14, 15 like deregulation of imprinted genes detected at H19/IGF2 locus in atherosclerotic tissue. 16 Only a few reports have addressed global DNA methylation in atherosclerotic lesions, 3, 17 and DNA methylation affecting individual genes has remained poorly studied. We applied methyl-cytosine dependent DNA precipitation followed by deep sequencing, which led to identification of 31 994 differentially methylated sites in atherosclerotic plaques when compared with healthy arteries. Differentially methylated sites were predominantly affected by hypomethylation. The most prominent continuous hypomethylated area was detected at imprinted locus 14q32, and hypomethylation correlated with increased gene expression including several miRNAs. Furthermore, reactivation of imprinted genes was demonstrated at chromosomal locus 14q32. We are also the first to report that gene body hypermethylation was correlated with increased mRNA expression in atherosclerotic plaques.
Methods
See Supplemental material online for details.
Human samples
Human femoral artery atherectomy samples (n ¼ 22) were compared with normal mammary artery samples (n ¼ 9). Atherosclerotic samples were collected at vascular atherectomy operations. 18 The normal samples represent trimmed ends of mammary arteries isolated during cardiac bypass surgery. Average age (+SD) of the patients for plaques and normal arteries were 70.9 + 7.3 and 67.2 + 9.1 years, respectively ( Table 1) . The studies were approved by Local Ethical Committee of Kuopio University Hospital under identification number 53/2011 and the subjects gave informed consent.
DNA methylation analysis
DNA samples isolated from arterial specimens were fragmented, and analysed after methyl-cytosine dependent fragment capture exploiting next-generation sequencing (NGS), followed by statistical and bioinformatical analysis. The raw data were submitted to Genome Omnibus public repository (GSE53575).
Gene expression analysis
Affymetrix HGU133 Plus2 microarrays (MA) (Affymetrix, CA, USA) comprising 54 675 probe sets were utilized as recommended by the manufacturer. The raw data were submitted to Genome Omnibus public repository (GSE53274).
Quantitative real-time polymerase chain reaction
Quantitative real-time polymerase chain reaction (qPCR) was performed using SYBR Green chemistry (Applied Biosystems) and the ABI StepOne Plus apparatus (Applied Biosystems). The primers were designed using Primer3. 19 Specific miRNAs were detected by commercial qPCR assays ordered from Exiqon (Vedbaek, Denmark).
Statistical analysis and bioinformatics
Next-generation sequencing reads were mapped to human chromosomes, and statistically significant differences [false discovery rate (FDR) adjusted P , 0.05, over 2.5-fold differential in DNA methylation] at specific loci were identified after normalization of read counts. Ingenuity Pathway Analysis (Ingenuity) was used for bioinformatical analyses of gene compartments with significant alterations in DNA methylation.
Results

Global findings in DNA methylation
Genomic sites showing significant differential methylation between healthy arteries and atherosclerotic plaques Sequenced MeCP2-precipitated DNA fragments were mapped to three distinct gene compartments: promoters, exons and introns. Significant (P , 0.05) alteration in DNA methylation in excess of 2.5-fold was detected at 4779 promoter sites (total of 187 012) corresponding to 3740 genes, at 8604 exon sites (of 246 889) corresponding to 4939 genes and at 17 782 intronic sites (of 1 713 622) representing 7972 genes (Supplementary material online, File S1). The lists of differentially methylated genes in the three compartments overlapped in different combinations ( Figure 1A) , and 278 genes exhibited differential DNA methylation in all three gene compartments.
The vast majority (84%) of differentially methylated promoter sites were hypomethylated (3997 sites corresponding to 3199 genes) in atherosclerotic plaques and only 782 promoter sites (16%) were hypermethylated (Supplementary material online, File S1). Similarly, the hypomethylated exon sites (8355; P , 0.05) clearly outnumbered the hypermethylated ones (249; P , 0.05, Supplementary material online, File S1). Differential DNA methylation was also detected in intronic sites, the majority being hypomethylated (14 412) compared with 3370 hypermethylated sites, which mapped to 6895 and 2524 individual genes, respectively (Supplementary material online, File S1). The number of genes showing hypomethylation in all three compartments was 212 ( Figure 1B ) while there was a single such gene [filamin A (FLNA)] demonstrating hypermethylation ( Figure 1C ). We observed that both hypo-and hypermethylated intronic areas belong to genes that are far longer (about 10-fold, i.e. 3000 vs. 30 000 base pairs) than an average gene.
Gene ontology analysis of hypomethylated genes in atherosclerotic plaques
Genes of known function showing differential methylation were analysed further for characteristic ontology groups (Supplementary material online, File S2). Gene ontology analysis of the 1555 genes associated with the most significantly hypomethylated promoters ( Figure 1B ) revealed 32 intermediate filament-related genes (.2.5-fold, P , 0.05; Supplementary material online, File S2) as the only group retaining significance after FDR correction for multiple testing. These genes included mainly keratins and keratin-associated proteins (28 genes out of 32, Supplementary material online, File S2).
Gene ontology groups of genes harbouring hypomethylated exons and introns shared extensive similarity consistent with the overlap seen in Figure 1C . These groups included ATP-binding proteins as well as cytoskeletal and chromatin regulator proteins (Supplementary material online, File S2). ATP-binding proteins from the hypomethylated exon group (375 genes), and from the hypomethylated intron group (557 genes), shared 217 overlapping genes (Supplementary material online, File S2). Overlaps of similar size were identified for cytoskeleton proteins, where 163 genes had both hypomethylated exon(s) and intron(s) from 376 and 410 genes, respectively (Supplementary material online, File S2). Similarly, 46 genes of chromatin regulators were shared between (A) 13 189 individual genes (Supplementary material online, File S1) showing significant (P , 0.05) in excess of 2.5-fold differences in DNA methylation at promoters, exons, or introns. All three compartments were affected in 278 genes. (B) In total 8246 genes of known function showing over 2.5-fold hypomethylation (at least at one of the three gene compartments-either in promoter, exon or intron) were identified. A small fraction (2.6%) of genes was hypomethylated simultaneously at all three genomic compartments. (C) Altogether 2466 genes of known function showed over 2.5-fold hypermethylation at least once (either at promoter, exon or intron). hypomethylated exons (78 genes) and hypomethylated introns (96 genes; Supplementary material online, File S2).
Gene ontology analysis of hypermethylated genes in atherosclerotic plaques
Ontological analysis of genes with hypermethylated promoters and exons did not reveal any enrichment for functional groups of genes. However, the list of ontology groups of genes harbouring hypermethylated introns shared some similarity with the ontology groups of genes exhibiting intron hypomethylation (Supplementary material online, File S2). The top groups of both lists are occupied by ATP-binding proteins followed by cytoskeleton, cell adhesion, and morphogenesis groups. ATP-binding proteins with hypomethylated (410 genes) and hypermethylated (218 genes) introns shared an overlap of only 25 genes (Supplementary material online, File S2).
Hypermethylation of gene compartments has a paradoxical effect on the level of mRNA expression in atherosclerotic plaques
Hypermethylation of gene promoters was more often correlated with mRNA down-regulation. Out of 556 unique genes with hypermethylated promoters, 271 were also present on MA ( Table 2) , and 11 genes showed .2.5-fold down-regulation of corresponding mRNA (Supplementary material online, File S3). FLNA is a unique gene among the list of 11 genes, as it is the only one which mRNA down-regulation (8-fold) was not only associated with promoter, but also with exon and intron hypermethylation (Supplementary material online, File S3). Counter intuitively, hypermethylation of gene bodies (exons and introns) was more commonly associated with an increase in mRNA expression ( Table 2) , and in total, 88% (¼479/547) of hypermethylated genes were transcriptionally up-regulated ( Table 2 , Supplementary material online, File S3).
Hypomethylated genes correlate with increased levels of mRNA expression
The vast majority (82% ¼ 1154/1400) of significantly hypomethylated and differentially (.2.5-fold) expressed genes exhibited increased mRNA expression ( Table 3 and Supplementary material online, File S3).
Local findings in DNA methylation
Altered DNA methylation at locus chr9p21 Chr9p21 is the strongest genetic susceptibility locus for cardiovascular diseases, and single nucleotide polymorphisms (SNPs) associated with disease locate to ncRNA gene CDKN2BAS. 27, 28 Differential methylation was detected at CDKN2BAS (exons 7 and 8, Supplementary material online, File S4). A hypomethylated area at the CDKN2BAS promoter (-1182 from transcription start site ¼ TSS, 985 base pairs in length) harboured 28 CpGs, independent of the adjacent CpG island, which overlaps the TSS. Furthermore, CDKN2BAS exon 7 is hypomethylated where exon 8 is hypermethylated (Supplementary material online, File S4). several thousand-fold enrichment for miRNA genes (total of 16, see Supplementary material online, Table S1 ), which predominantly located to chromatin locus 14q32 (10 genes, Supplementary material online, Table S1 and Figure S1 ). Induced expression of eight genes belonging to 14q32.2 (hsa-miR-127, -136, -410, -431, -432, and -433, Figure 2A ; RTL1, and MEG3; see Figure 2B ) was confirmed by qPCR, while the expression of two genes also belonging to chr14q32 (LINC00523, DIO3) was down-regulated ( Figure 2C ) in atherosclerotic arteries. MEG3 expression showing a three-to four-fold up-regulation in lesions was also detected by MA (Supplementary material online, File S3).
Imprinted locus 14q32 is hypomethylated
Five of the miRNAs (hsa-miR-127, -136; -431, -432, and -433) verified by qPCR, overlap with the protein coding gene RTL1. Hsa-miR-410 is a member of miRNA cluster of about 50 miRNAs and is located telomerically to the DLK1-MEG3-RTL1 -MEG8 gene cluster (Figure 3) overlapping with a CpG island. All six miRNAs showed prominent four-to eight-fold up-regulation in comparison to normal arteries (Figure 2) .
Locus 14q32 in atherosclerotic lesions is enriched for hypomethylated miRNA promoters (25 genes), and only two hypomethylated miRNA promoters could be detected elsewhere on Chr14 (Supplementary material online, File S5) . The total number of hypomethylated (.2.5-fold) miRNA promoters in lesions was 85 (Supplementary material online, File S5). Chr14 exhibited an outstanding disproportion in miRNA gene hypomethylation when compared with other chromosomes (Supplementary material online, File S5). The telomeric end of the long arm of chr14 includes 195 (including 45 protein expressing) genes, and 70 (28 protein coding genes) of those were hypomethylated (Supplementary material online, File S4).
Protein expression
RTL1 gene expression was up-regulated on mRNA (Figure 2) , and protein levels in lesions (Figure 3) . RTL1 expression was detected in smooth muscle actin-positive cells and in CD68-positive cells (Figure 4) , but not in endothelium. The expression of RTL1 protein in atherosclerotic lesions could also be demonstrated on western blot ( Figure 5 ).
Discussion
In this study, we have identified global alterations in DNA methylation characterizing atherosclerotic plaques, and at individual gene level. The effects of differential DNA methylation on gene expression were detected by MA analysis. We present evidence that DNA hypomethylation correlating with the expression of multiple genes may play a major role in atherogenesis, in particular, the newly identified reactivation of imprinted genes at locus chr14q32.2 is intriguing.
DNA hypermethylation
DNA methylation is an essential part of the epigenetic memory that allows cells to retain their specific pattern of gene expression and increased methylation has been commonly linked to downregulation of gene expression. 4 Genome-wide analysis revealed that in atherosclerotic plaques hypermethylation correlating with the down-regulation of gene expression was a relatively rare event ( Table 2) . Unexpectedly, DNA hypermethylation of exons and introns was associated with increased mRNA expression and 88% of genes showing hypermethylation at least in one gene compartment correlated with .2.5-fold increase in mRNA expression ( Table 2) . To the best of our knowledge, stimulated mRNA expression correlating with hypermethylation of gene bodies has not been reported previously. In normal cells, it has been detected that hypermethylation of gene bodies in comparison to corresponding promoters was positively correlated with gene transcription, 20,21 possibly due to less frequent transcriptional activation from internal promoters. 22 Enrichment for ATP-binding and cytoskeletal proteins was detected among hypermethylated genes, and this is of interest because the same two protein classes also appear highly significant among hypomethylated genes (Supplementary material online, File S2).
DNA hypomethylation
General DNA hypomethylation in atherosclerotic plaques 3, 13 was confirmed by this study and sites showing .2.5-fold decrease in DNA methylation were 3.6-fold more numerous than hypermethylated sites (11 729 vs. 3245, Tables 2 and 3 ). The large number (26 766 out of 31 175, i.e. 86%) of highly and significantly (FDR-adjusted P , 0.05) hypomethylated genomic sites in plaques lends support to the idea that general hypomethylation may be a random process. Support of this assumption comes from the fact that hypomethylated genes were much longer than an average gene is (30 000 vs. 3000 bp), and are more likely to become unmethylated.
Hiltunen et al. 3 reported that hypomethylation correlates with increased general transcription. Current report gives support to this notion and we noticed that hypomethylated genes showing over 2.5× enhancement in mRNA expression in plaques are about 5-fold more numerous than hypomethylated and down-regulated genes (1154 vs. 246 genes, Table 3 and Supplementary material online, File S3). This predominance of hypomethylated genes exhibiting increased gene expression is notably high and the idea of reversal of the global level of DNA hypomethylation as part of therapy appears attractive. This could be achieved either by increasing circulating levels of S-adenosylmethionine, reducing S-adenosylhomocysteine levels or by inhibiting DNA demethylating enzymes.
Hypomethylation of local genomic areas in atherosclerosis
The strongest genetic risk factor for atherosclerosis has been mapped to chromosomal locus 9p21 (chr9p21), 23 but gene expression levels (MTAP, CDKN2A, CDKN2B, and CDKN2BAS) located to chr9p21 have not been shown to correlate with disease-associated SNPs. 24 Consequently, epigenetic factors (e.g. DNA methylation, histone modifications) may account for the association of SNPs with atherosclerosis. Chr9p21.3 encompassing 5 Mbp is relatively poor in CpG islands, and the two differentially methylated sites detected (CDKN2BAS hypomethylated exon 7 and hypermethylated exon 8, Supplementary material online, File S4) locate outside of CpG islands. These changes in DNA methylation may be important as the strongest genetic susceptibility of chr9p21 locus has been narrowed down to a 50 kbp region in CDKN2BAS gene 23 which overlaps with the two identified sites in exons 7 and 8.
Apart from the chr9p21, we are the first to report that DNA hypomethylation affects the telomeric end of the long arm of chromosome 14 peaking at locus chr14q32.2. This locus (Figure 3) encodes for maternal ncRNA genes (MEG3, MEG8, DIO3AS, and RTL1AS) and paternally expressed protein genes (DLK1, RTL1, and DIO3). Locus chr14q32.2 encodes for over 60 miRNAs and 70 snoRNAs. Among the protein coding genes RTL1 appears to be the most interesting, as the normal developmental role for RTL1 is essential for maintenance of foetal capillaries 25 and re-expression in adults may contribute to intra-plaque de novo capillary formation and/or plaque destabilization, which is often seen in advanced vulnerable plaques. 26 RTL1 gene overlaps with hsa-mir-127, which is upregulated in atherosclerotic plaques (Figure 2A) and has been previously shown to be overexpressed in unstable carotid plaques. 27 As both RTL1 and hsa-mir-127 appear up-regulated in human plaques (Figure 2A and B) , they may contribute to atherosclerotic lesion formation.
Reactivation of H19 expression has been detected in human coronary artery atherectomy samples. 16 However, H19 expression in femoral lesions remained unchanged (MA result, data not shown), and there were no detectable alterations in H19 gene methylation (Supplementary material online, File S4). Hsa-mir-675 and hsa-mir-483 exhibited hypermethylation (1.5-to 2-fold, Supplementary material online, File S4), which is apparently insufficient to alter the imprinting status of H19/IGF2 gene expression. The observed reactivation of H19/IGF2 locus 16 may involve other mechanisms of genetic regulation.
miRNAs
Each miRNA gene has been predicted to regulate more than 100 genes, 28 but to downsize the range of candidate proteins, we searched differentially expressed genes for possible miRNA targeting. Only among down-regulated mRNAs (over 2.5-fold), Targetscan 6.2 predicted 40 genes (Supplementary material online, File S5) potentially regulated by six identified miRNAs (hsa-mir-431, -433, -127, -432, -136, -410), which expression was confirmed by qPCR.
The regulation of miRNA gene expression at chr14q32.2 is poorly studied, but RTL1AS (encoding for hsa-mir-431, -433, -127, -432, -136) has been shown to be transcribed as a single transcription unit. 29 Significantly hypomethylated miRNAs in atherosclerosis include five miRNAs (hsa-mir-431, -433, -127, -432, and -136) overlapping with RTL1 at chr14q32.2. Hsa-miR-127 has been shown to regulate BCL6 30 and hsa-miR-432 to down-regulate ADAR1 in melanoma. 31 In solid tumours hsa-mir-431, -433, -127, -432, and -136 were down-regulated in comparison to normal tissues. 32 Imprinting represents mitotically stabile inheritable epigenetic marks, which are common to genes required for early development and placental growth. Reactivation of imprinted genes has been previously detected in cancers 33 and now we also demonstrated its occurrence in atherogenesis. Loss of imprinting contributes to the expression of genes regulated by miRNAs. 
Protein expression
The intermediate filament ontology group was the only group significantly overrepresented among genes with hypomethylated promoters (Supplementary material online, File S2). Keratin mRNAs were up-regulated in plaque MA analysis (Supplementary material online, File S3). Keratins are characteristic to epithelial cells and are not expressed in normal arteries. Induction of keratin expression in atherosclerosis has been detected previously, 34 and it appears that DNA hypomethylation may play a role in keratin gene activation and ectopic keratin expression.
FLNA protein crosslinks actin network and has been shown to be down-regulated at protein level in atherosclerosis. 35 In our study, FLNA is a unique gene exhibiting hypermethylation at all three gene compartments and FLNA mRNA was down-regulated approximately eight-fold in plaques (Supplementary material online, File S3). It has been suggested that filamin down-regulation can be protective against phenotypic switch of smooth muscle cells in atherosclerosis, and our results suggest that DNA hypermethylation is a potential mechanism for the observed down-regulation of FLNA expression. RTL1 expression in lesions was an unexpected finding, as miRNAs complementary to RTL1 were detected in excess and hsa-miR-127, -136, and -431 have been shown to induce RTL1 mRNA cleavage. 29 To date, miRNA target site prediction algorithms even do not consider internal binding sites although the usage of internal miRNA binding sites for RTL1 mRNA cleavage has been demonstrated. 29 Atherosclerotic tissue exhibits a patchy pattern of RTL1 expression ( Figure 3) , but whether RTL1 expression is a cause or a consequence remains to be clarified.
Conclusion and limitations of the study
The strongest genetic risk factors of atherosclerosis can cumulatively explain only as little as 11% of the observed inheritance of atherosclerosis. 36 Consequently, epigenetic factors are likely to contribute to the inheritability seen in atherosclerosis. We are just at starting to become aware about the role and complexity of underlying epigenetic mechanisms in health and disease. Our genome-wide analyses of atherosclerotic lesions have highlighted the extensive modifications in DNA methylation, which may be involved in atherogenesis. Larger studies combining epigenome, transcriptome and clinical data are needed to further clarify the interactions between epigenetics and atherogenesis.
Limitations of this study include the relatively small number of samples representing femoral artery lesions, successively (not in a randomized fashion) recruited patients were only of caucasian origin and the study was conducted only in a single center. Also, femoral atherectomy samples may not be entirely similar to earlier type of lesions or so-called vulnerable plaques. 26 Despite these limitations, the presented results will allow a better understanding of the epigenetic mechanisms operational in atherogenesis and will help to design potential new therapeutic interventions. 37 
